Requirement of Estrogen Receptor-α in Insulin-like Growth Factor-1 (IGF-1)-induced Uterine Responses and in Vivo Evidence for IGF-1/Estrogen Receptor Cross-talk

Autor: Jonathan Lindzey, Michele Raviscioni, Richard P. DiAugustine, Julie F. Foley, Paolo Ciana, Diane M. Klotz, Kenneth S. Korach, Sylvia C. Hewitt, Adriana Maggi
Rok vydání: 2002
Předmět:
Time Factors
Transcription
Genetic

medicine.medical_treatment
Estrogen receptor
Biochemistry
Mice
Phosphatidylinositol 3-Kinases
Insulin-like growth factor
Insulin-Like Growth Factor I
Luciferases
Promoter Regions
Genetic

Fulvestrant
Mice
Knockout

Estradiol
biology
Estrogen Antagonists
Immunohistochemistry
Receptors
Estrogen

Female
Signal transduction
Cell Division
Protein Binding
Signal Transduction
medicine.medical_specialty
medicine.drug_class
Immunoblotting
Alpha (ethology)
Mice
Transgenic

Protein Serine-Threonine Kinases
Response Elements
Models
Biological

Proto-Oncogene Proteins
Internal medicine
medicine
Animals
Molecular Biology
Estrogen receptor beta
Cell Nucleus
Uterus
Estrogen Receptor alpha
Cell Biology
Precipitin Tests
Enzyme Activation
Insulin receptor
Endocrinology
Bromodeoxyuridine
Estrogen
biology.protein
Proto-Oncogene Proteins c-akt
Estrogen receptor alpha
Zdroj: Journal of Biological Chemistry. 277:8531-8537
ISSN: 0021-9258
Popis: In the uterus insulin-like growth factor-1 (IGF-1) signaling can be initiated by estradiol acting through its nuclear receptor (estrogen receptor (ER)) to stimulate the local synthesis of IGF-1. Conversely, in vitro studies have demonstrated that estradiol-independent ER transcriptional activity can be induced by IGF-1 signaling, providing evidence for a cross-talk mechanism between IGF-1 and ER. To investigate whether ER alpha is required for uterine responses to IGF-1 in vivo, both wild-type (WT) and ER alpha knockout (alpha ERKO) mice were administered IGF-1, and various uterine responses to IGF-1 were compared. In both WT and alpha ERKO mice, IGF-1 treatment resulted in phosphorylation of uterine IGF-1 receptor (IGF-1R) and formation of an IGF-1R/insulin receptor substrate-1/ phosphatidylinositol 3-kinase signaling complex. In addition, IGF-1 stimulated phosphorylation of uterine Akt and MAPK in both WT and alpha ERKO mice. However, IGF-1 treatment stimulated BrdUrd incorporation and proliferating cell nuclear antigen expression in WT uteri only. To determine whether ER alpha can be activated in vivo by IGF-1 signaling, transgenic mice carrying a luciferase gene driven by two estrogen response elements (ERE-luciferase mice) were utilized. Treatment of ovariectomized ERE-luciferase mice with IGF-1 resulted in an increase in uterine luciferase activity that was attenuated in the presence of the ER antagonist ICI 182,780. Together these data demonstrate that 1) functional signaling proximal to IGF-1R is maintained in the alpha ERKO mouse uterus, 2) ER alpha is necessary for IGF-1 induction of uterine nuclear proliferative responses, and 3) cross-talk between IGF-1R and ER signaling pathways exists in vivo.
Databáze: OpenAIRE